Both MNCs, Local Korean Pharmas Under Korean Government Surveillance For IP Protection
This article was originally published in PharmAsia News
Executive Summary
SEOUL - In its first examination into intellectual property rights related to deals among pharma companies operating in Korea, South Korea's Fair Trade Commission is now accepting complaints and opinions from 30 leading multinational companies and 18 local Korean companies